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Abstract
The molecular mechanisms of strain-specific probiotic effects and the impact of the oral
administration of probiotic strains on the host’s gene expression are not yet well understood.
The aim of this study was to investigate the strain-specific effects of probiotic strain intake
on gene expression in the murine small intestine. Two distinct strains of lactic acid bacteria,
Lactobacillus rhamnosus GG (GG) and Lactococcus lactis subsp. lactis C59 (C59), were
orally administered to BALB/c mice, daily for 2 weeks. The total RNA was isolated from the
upper (including the duodenum) and lower (the terminal ileum) small intestine, and gene
expression was assessed by microarray analysis. The data revealed (1) oral administration
of C59 and GG markedly down-regulated the expression of genes encoding fibrinogen sub-
units and plasminogen in the upper small intestine; (2) administration of more than 1 × 107
CFU/day of GG changed the gene expression of the host ileum. (3) strain- and dose-related
effects on various GO biological processes; and (4) enrichment for B cell-related Gene
Ontology terms among up-regulated genes in the terminal ileum of mice administered the
1 × 109 CFU/day of GG. The distinct effects of GG and C59 on gene expression in the intact
small intestine provide clues to understand how the health beneficial effects of specific
strains of probiotic bacteria are mediated by interactions with intestinal cells.
Introduction
Probiotics are defined as “live microorganisms, which, when administered in adequate
amounts, confer a health benefit on the host” [1]. Various strains of lactic acid bacteria (LAB)
and bifidobacteria are utilized as probiotics and exert strain-specific beneficial effects on health
by regulating the gut ecosystem, preventing pathogen adherence, and interacting with gut
associated lymphoid tissue [2, 3]. The beneficial health effects of probiotics partially depend on
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the components of the bacterial cell, such as peptidoglycan, lipoteichoic acids, and bacterial
DNA, known as microbe-/pathogen-associated molecular patterns (MAMPs/PAMPs) [4].
Interaction between Toll-like receptors (TLRs) and those bacterial components, as TLR
ligands, are thought to mediate the interaction between the host’s epithelial immune cells and
probiotic cells [4, 5]. Metabolites produced by probiotics also contribute to their beneficial
health effects. For example, acetate produced by bifidobacteria modulates the intestinal defense
responses of the host and protects epithelial cells from infection [6]. Furthermore, butyrate
produced by the microbiota in the large bowel induces the differentiation of colonic Treg cells in
mouse [7]. Animal models of various diseases or samples from patients [8, 9] are used to investi-
gate the effects of probiotics, but the intestinal responses of healthy animals to probiotics have
not been investigated. In addition, although many studies have reported the beneficial effects of
probiotics, there have been few comparative studies of probiotics. Further, since the number of
indigenous microbiota in the intestine is estimated to be 1012−14 cells, it is unclear how probiotics
could have a beneficial effect when the ratio of intestinal bacteria to probiotic bacteria may be as
low as 1:100,000 after probiotic administration. However, supplemented probiotics may manifest
their effects on intestinal microbiota via the host’s immunity. The host immune system may
react to the administered LAB and mount specific responses to strain-specific components. The
lack of an appropriate control LAB strain has made it difficult to compare the effects of different
probiotics. Conventionally, a probiotic strain and a vehicle control are used for oral administra-
tion, but a vehicle control is only rarely satisfactory. In this study, we tried to overcome this diffi-
culty by studying the strain-specific effects of two orally administered LAB strains.
Lactobacillus rhamnosus GG (GG) is one of the most extensively studied probiotic strains.
GG was originally isolated from fecal samples of a healthy human adult [10] and is resistant to
bactericidal agents in the intestinal environment, such as high gastric acid and bile concentra-
tions, and can adhere to the intestinal epithelial layer via pili [11–13]. The beneficial effects of
GG intake on the gut microbiota have also been investigated [14, 15]. GG inhibits the adher-
ence of pathogens to the intestinal epitherium, enhances the epithelial barrier function, and
modulates host immune responses [16, 17]. Neonatal colonization of mouse by GG promotes
intestinal development and protects the intestine from inflammation, maintaining the host’s
health [18]. In various disease models, such as allergic diseases [19], and colitis and obesity
[20], administration of Lactobacillus GG alleviates the symptoms of disease [11, 21]. Further-
more, randomized trials demonstrated beneficial effects of GG ingestion on atopic disease [22,
23], nosocomial gastrointestinal infections [24], pediatric obesity-related liver disease [25],
and acute gastroenteritis in children [26].
Lactococcus lactis subsp. lactis C59 was isolated from cheese at the Institute of Livestock and
Glassland Science, NARO [27]. Contrary to the strong immunostimulatory activity of GG, the
immunostimulatory activity of C59 is very low. Its ability to stimulate a macrophage-like cell line
J774.1 to induce interleukin (IL) 12 and interferon (IFN) γ was the weakest from a panel of 10
Lactobacillus and Lactococcus strains [28]. Upon the administration of live C59, the strain sup-
presses the increase of serum IgE antibody levels in ovalbumin (OVA)-sensitized mouse [28]. Ex
vivo experiments revealed that the inhibition of IgE antibody production by C59 is caused by the
suppression of IL-4 production [28], in a manner different from strains that enhance the Th1
response. By contrast to the adherence of GG to the intestinal epithelial layer, C59 is excreted live
in feces within a day of administration, suggesting that it does not adhere to intestinal cells [28].
Various MAMPs implicated in the beneficial effects of GG, such as immunostimulatory oli-
godeoxynucleotides in the GG genomic DNA [29], the pili [30], lipoteichoic acid [31, 32], and
surface proteins [33], have been investigated. The stimulation of Tlr3 gene expression by GG is
observed both ex vivo and in vivo [34]. TLR3 is a nucleotide-sensing TLR, which is activated by
double-stranded RNA (dsRNA). LAB contain more dsRNA than pathogenic bacteria and
Lactic acid bacterium intake and murine ileal gene expression
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trigger IFN-β production [35]. The GG cell surface contains high molecular weight, galactose-
rich heteropolymeric exopolysaccharide (EPS) molecules, which may negatively impact the
adherence of GG, possibly by shielding the adhesins [36]. On the other hand, C59 harbors
unique EPS consisting of glucose, N-acetylglucosamine, and rhamnose, although most L. lactis
EPS molecules analyzed thus far contain galactose [37]. An in vitro experiment showed that
C59 may activate plasminogen; it converts plasminogen to plasmin in a reaction catalyzed by a
serine protease [38]. Thus, GG and C59 have distinct characteristics.
The aim of this study was to investigate the effect of oral administration of LAB strains C59
and GG on the gene expression in the murine small intestine, i.e., the first site of probiotic
interaction with the host’s intestinal cells. By using two distinct LAB strains, we expected to
detect common responses and administered strain-specific responses. Comparison of the
effect of these distinct strains on the gene expression in the small intestine could help elucidate
the distinct responses of intestinal cells and the strain-specific mechanism of probiotics.
Materials and methods
Bacterial strains
Strain GG (ATCC 53103) was kindly provided by Takanashi Milk Products Co. Ltd. GG was
cultured in Difco lactobacilli de Man, Rogosa and Sharpe broth (MRS) (Becton Dickinson,
Sparks, MD) for 18 h at 37˚C. Strain C59 was isolated from cheese [27] and is maintained in
the LAB collection at NILGS (Institute of Livestock and Glassland Science, NARO). C59 was
grown in Difco M17 broth (Becton Dickinson) containing 0.5% glucose as a carbon source
(GM17) for 18 h at 30˚C. Bacterial cells were harvested by centrifugation at 6000 × g for 15
min at 4˚C, and washed twice with phosphate-buffered saline (PBS); bacterial cell suspensions
(OD620 = 10) were prepared in PBS. The suspensions were divided into small aliquots and
stored at -80˚C until administration.
Animal experiments
All animal care and use protocols were implemented in accordance with the animal experi-
mentation guidelines of the National Agriculture and Food Research Organization (NARO;
Ibaraki, Japan). The study protocol was approved by the Animal Care Committee at the
National Institute of Livestock and Grassland Science (Ibaraki, Japan; permit numbers:
07062806, 08032651, and 09032637).
Six-week-old male BALB/c (Balb/cAnNcrl) mice (n = 90; average starting weight, 23.0 g)
were purchased from Charles River Japan, Inc. (Kanagawa, Japan) and acclimatized for 1 week
before the start of experiments. Three animals were housed per cage under a 12 h light/dark
cycle and allowed free access to water. The basic feed was a nutritionally complete diet (AIN-
93G, Oriental Yeast, Tokyo, Japan). The mice had ad libitum access to water and the diet. In
each experiment, mice in the control group received 0.2 ml of phosphate buffer saline (PBS)
and mice in the LAB administered groups received 0.2 ml of bacterial suspension in PBS, once
per day for 15 days, using an intragastric stainless steel feeding tube. The final LAB administra-
tion was followed by a 3 h fast to make the period from the last feed equal. Then, the mice were
sacrificed by cervical dislocation under pentobarbital anesthesia (5%, 75 μl/mouse).
Experiment 1 involved three groups of animals (control, GG, and C59 groups; n = 6 animals
per group) (Fig 1A). Mice in the GG and C59 groups received bacterial suspensions [OD620 =
10, corresponding to 1 × 109 colony-forming units (CFU) per day] of GG and C59, respec-
tively,. After sacrifice, the upper small intestine (2 cm) and the lower small intestine (the termi-
nal ileum; 2 cm) were excised, and immediately placed in RNAlater (QIAGEN, Valencia, CA).
RNA was prepared using an RNeasy kit (QIAGEN).
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Experiment 2 involved seven animal groups (control, GG-10^7, GG-10^8, GG-10^9, C59-
10^7, C59-10^8, and C59-10^9 groups; n = 6 per group per experiment) (Fig 1B). Mice in the
GG-10^7, GG-10^8, and GG-10^9 groups received GG suspensions corresponding to 1 × 107
CFU/day, 1 × 108 CFU/day, and 1 × 109 CFU/day, respectively. Mice in the C59-10^7, C59-
10^8, and C59-10^9 groups received C59 suspensions corresponding to 1 × 107 CFU/day,
1 × 108 CFU/day, and 1 × 109 CFU/day, respectively. The feces of each mouse were collected
before administration on the first day and after administration on the last day, and suspended
by vortex-mixing to a final concentration of 0.1 g of wet weight/ml in PBS containing 1% fetal
calf serum. Fecal extracts were obtained by centrifugation (10,000 × g, 10 min) and kept at
-80˚C until use. At day 15, the lower small intestine was taken, and RNA was purified as
described above. The body weight gain during the Experiment 2 was analyzed using the
MIXED procedure of SAS (SAS Institute, Cary, NC).
Experiment 3 was performed in the same way as Experiment 1. The small intestine was
removed and intestinal fluids, obtained by flushing the small intestine with 10 ml PBS, were
kept at -80˚C until use.
Experiment 4 was performed in the same way as Experiment 1 with two groups of mice
(control and GG). The small intestine was removed and used to isolate lymphoid follicles
(described below).
Fig 1. Outline of the animal experiments. (A) Experiment 1. The mice were divided into three groups (control, C59, and GG groups; n = 6 per group) and
administered 0.2 ml of PBS (control) or LAB suspensions (C59 and GG groups) for 2 weeks. (B) Experiment 2. The mice were divided into seven groups
(control, GG-10^7, GG-10^8, GG-10^9, C59-10^7, C59-10^8, and C59-10^9 groups; n = 6 per group per experiment) and was performed in duplicate
(round-1 and round-2). Round 2 (n = 3 per group) started a week after the start of the round 1 (n = 3 per group).
https://doi.org/10.1371/journal.pone.0188985.g001
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Microarray analysis
The GeneChip mouse 430 2.0 array; one-cycle target labeling and control reagents kit; and
hybridization, wash, and stain kit were purchased from Affymetrix (Santa Clara, CA). Total
RNA (5 μg) from the upper and lower intestine samples from five randomly selected mice was
processed to prepare biotin-labeled complementary RNA using one-cycle target labeling and
control reagents kit according to the manufacturer’s instructions. Biotin-labeled cRNA was
fragmented and used as a probe for hybridization to the GeneChip mouse 430 2.0 array. Fluo-
rescence data were scanned by a GeneChip Scanner controlled by the GeneChip operating
software (GCOS) 1.2 (Affymetrix).
DNA microarray data analysis
Affymetrix GCOS software was used to convert the array images to numerical values indicating
the intensity of each probe (CEL files). The microarray data were analyzed using the statistical
language R (http://www.r-project.org/) and Bioconductor (http://www.bioconductor.org/). The
annotation file for the mouse 430 2.0 array was downloaded from Affymetrix (http://www.
affymetrix.com/). The CEL file data were quantified using robust multi-array analysis (RMA)
[39]. To identify differentially expressed genes (DEGs), the rank products method [40] was used
(number of permutations = 1000, cut-off = 0.05). Probe sets with a false discovery rate (FDR)
<0.05 were considered to indicate DEGs. Principal component analysis (PCA) was performed
using the R function ‘prcomp’. Principal component scores of experimental groups were com-
pared using ANOVA and Tukey’s test. The component loadings of PC1 and PC3 of each gene
were plotted to detect genes contributing to PC1 and PC3. The gene list enrichment analysis was
performed using PANTHER v. 11.1 (Protein ANalysis THrough Evolotionary Relationships,
http://pantherdb.org) [41]. The lists of up-regulated or down-regulated genes (FDR< 0.05)
were analyzed by a PANTHER over-representation test (released July 15, 2016) with the Gene
Ontology (GO) database (released December 28, 2016). We considered GO terms that had 30–
300 genes [42]. All microarray data were submitted to the National Center for Biotechnology
Information (NCBI) Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/): dataset
GSE72804 for the upper and lower small intestine data, and GSE84949 for the dose effect data.
Enzyme-linked immunosorbent assay (ELISA)
Total IgA concentration in the fecal extracts or intestinal fluids was determined using a mouse
IgA enzyme-linked immunosorbent assay (ELISA) quantitation set (Bethyl Laboratories, Inc.,
Montgomery, AL). Protein concentrations of intestinal fluids were determined by the BCA
protein assay kit (Pierce). The concentration of IgA before and after the oral administration of
LAB was analyzed using the MIXED procedure of SAS (SAS Institute). The effect of LAB treat-
ment (LAB-treat; control vs. six LAB administration groups), days (Days; before and after
administration), and the interaction of LAB-treat and Days parameters were analyzed. The dif-
ference of the concentration of IgA in intestinal fluids between the control and the sCSDS
groups (Experiment 3) was analyzed by ANOVA. Because the difference of the concentration
in IgA was not significant, a post hot test was not performed.
Immunostaining of the isolated lymphoid follicles (ILFs) in the small
intestine
The small intestines of mice in Experiment 4 were analyzed. The immunostaining detection of
isolated lymphoid follicles (ILFs) was performed according to the method of McDonald and
Newberry [43], with some modifications. The ILF immunostaining protocol has been
Lactic acid bacterium intake and murine ileal gene expression
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deposited in protocols.io (dx.doi.org/10.17504/protocols.io.jr3cm8n). The CXCR5-positive
ILFs in each segment were independently counted under a stereomicroscope by three investi-
gators, and the number of CXCR5-positive ILFs were averaged in each segment. The numbers
of ILFs in control groups and the GG-administered group were statistically compared using
Student’s t-test.
Results and discussion
The effect of LAB administration on gene expression in the upper and
lower regions of the small intestine
In Experiment 1, gene expression in the upper (including the duodenum) and lower (the ter-
minal ileum) small intestine was compared to identify the region of the small intestine that is
affected by LAB strain administration (Fig 1A). After 2 weeks of the administration period,
gene expression in the upper and lower small intestine was analyzed using the GeneChip
mouse 430 2.0 array with 45,101 native features. We applied three quantification methods
(RMA [39], DFW [44], and qFARMS [45]) to the raw data. Hierarchical cluster analysis
revealed that three methods did not provide good segregation when expression data of 45,101
probes were used, suggesting that administration of a strain of LAB did not affect overall gene
expression (S1 Fig). Microarray data from the three animal groups were quantified using
RMA followed by collapsing features into gene symbols and 21,815 genes were further
analyzed.
Rank products analysis [40] was more sensitive in detecting DEGs (FDR< 0.05) in the con-
trol group and groups administered LAB (S1–S4 Tables). The number of DEGs in the upper
small intestine and terminal intestine of each mouse administered C59 and GG were shown in
Table 1. Total number of DEGs was higher in the terminal ileum than in the upper small intes-
tine of both C59- and GG-administered mice, suggesting that the terminal ileum is more suit-
able for investigating the effects of administration of LAB strains.
To detect biological processes defined by GO that were affected by the administration of
LAB, gene list enrichment analysis using the PANTHER over-representation test was
employed, using lists of up-regulated or down-regulated genes (FDR< 0.05) in each LAB-
administered group (Table 2). In the upper small intestine, the administration of C59 down-
regulated the same biological processes as the administration of GG, suggesting that the effects
were LAB-specific but not strain-specific. Fga, Fgb, and Fgg encoding fibrinogen subunits, and
Plg encoding plasminogen, were significantly down-regulated (FDR<0.05) in groups adminis-
tered both C59 and GG, among the genes associated with the biological processes
Table 1. Number of differentially expressed genes (DEGs, FDR < 0.05)) in upper small instestine and terminal ileum of mice administered C59 and
GG.
small intestine upper small intestine terminal ileum
administered LAB C59 GG common DEGsa C59 GG common DEGsa
up-regulated 94 83 (37) 132 95 (30)
(5)b
down-regulated 47 89 (32) 172 142 (43)
(24)c (4)c
total 141 172 304 237
a Number of common DEGs represented in () is included in respective DEGs in C59 and GG.
b DEGs up-regulated in GG-administered mice and down-regulated in C59-administered mice.
c DEGs up-regulated in C59-administered mice and down-regulated in GG-administered mice.
https://doi.org/10.1371/journal.pone.0188985.t001
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“plasminogen activation”, “positive regulation of heterotypic cell-cell adhesion”, and “fibrino-
lysis”. These genes were not detected as DEGs in the terminal ileum. This observation raised
the possibility that down-regulation of fibrinogen subunit and plasminogen gene expression in
the upper small intestine might be a general effect of LAB administration. The oral administra-
tion of Lactobacillus casei CRL431 was shown to activate effectively coagulation and inhibit
fibrinolysis during a pneumococcal infection; this was mediated by an induction of high levels
of IL-4 and IL-10 [46]. In the current study, the oral administration of C59 or GG did not sig-
nificantly affect the expression of Il4 and Il10 in either the upper or lower small intestine in a
healthy mouse. Whether administration of LAB affects blood coagulation itself by down regu-
lating of expression of coagulation-related genes remains to be investigated. With respect to
Plg gene expression in the upper small intestine, although it has been shown that the cell sur-
face components of C59 can activate plasminogen in vitro [38], the effect of oral administra-
tion of C59 could be distinct from the in vitro mechanism.
By contrast to the upper small intestine, common biological processes affected by the oral
administration of C59 or GG were not identified in the terminal ileum and only administra-
tion of GG affected several biological processes, suggesting a GG-specific effect in that intesti-
nal segment. Significant (p< 0.05) enrichment of B cell-related GO terms was observed
among up-regulated genes in the group administered GG. The following DEGs were associ-
ated with “brown fat cell differentiation”: Adb3, Adig, Adipoq, Fabp4, and Scd1. The following
DEGs associated with “lymph node development”, “B cell receptor signaling pathway”, “B cell
activation”, “cell chemotaxis”, and “adaptive immune response” were identified: Arhgef16, Blk,
Ccr6, Ccr7, Cd79a,Cd79b,Cr2, Cxcr13,Cxcr5, Fcamr, Ighg, Klhl6, Ltb, Ms4a1, Pdgfra, Saa2,
Saa3, and Tnfrsf13c. These results suggest that GG administration exerts a more pronounced
effect on the activation of immune cells than C59 administration. Pronounced immunostimu-
latory effects of GG have been reported in various studies [16, 17, 29–31, 47]. Our results con-
firmed these immunostimulatory effects, as reflected by the host’s intestinal gene expression.
Since more DEGs were detected in the terminal ileum and GG-specific enrichment was
observed when the terminal ileum was examined, we decided to focus on the terminal ileum in
subsequent analyses.
The effect of strain and dose of orally administered LAB on the gene
expression in the terminal ileum
In Experiment 1, we showed that oral administration of 109 CFU/day of C59 or GG for 2
weeks significantly changed intestinal gene expression. To evaluate the strain-specific and
dose-related effects of LAB on gene expression in the terminal ileum, 1 × 107, 1 × 108, and
1 × 109 CFU/day of strains C59 and GG were administered in Experiment 2 (Fig 1B).
Throughout the experiment, the administration of various doses of LAB had no effect on ani-
mal body weight gain. The DEGs between the control group and each LAB administered
group were identified using rank products analysis (Table 3, S5–S10 Tables) [40]. Among up-
and down-regulated DEGs, number of common DEGs were also counted in C59- and GG-
administered groups, respectively (Table 3). 134 up-regulated DEGs and 6 down-regulated
DEGs were found in all LAB-administered groups. To clarify the reproduction of DEGs in
Experiment 1 (Table 1) and Experiment 2 (Table 3), up- and down-regulated DEGs were com-
pared. In the case of C59-administered group, 31 genes (23%) out of 132 up-regulated DEGs
in Experiment 1 were reproduced in Experiment 2 (C59-10^9 group), whereas only 15 genes
(8.7%) out of 172 down-regulated DEGs were reproduced. In the case of GG-administered
group, 36 genes (38%) out of 95 up-regulated DEGs and 9 genes (6%) in 142 down-regulated
DEGs in Experiment 1 were reproduced in Experiment 2 (Table 3, GG-10^9). Although C59-
Lactic acid bacterium intake and murine ileal gene expression
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10^9 and GG-10^9 groups showed the highest number of DEGs, no clear dose-dependent
effects on the number of DEGs were observed.
Table 2. PANTHER Overrepresentation Test of gene expression in upper small intestine and terminal ileum of mice administered C59 and GG.
Intestine LAB up/ down
() *
GO biological process Ref-list
(22322)
loaded expected Fold
enrichment
P-value
upper small
instestine
C59 up digestion (GO:0007586) 94 10 0.37 27.0 4.69E-
08
(94) carbohydrate transport (GO:0008643) 78 6 0.31 19.5 6.17E-
03
steroid metabolic process (GO:0008202) 197 9 0.78 11.6 7.92E-
04
response to nutrient levels (GO:0031667) 238 9 0.94 9.6 3.81E-
03
down
(47)
plasminogen activation (GO:0031639) 10 4 0.02 > 100 2.35E-
05
positive regulation of heterotypic cell-cell adhesion
(GO:0034116)
10 3 0.02 > 100 5.99E-
03
fibrinolysis (GO:0042730) 15 4 0.03 > 100 1.18E-
04
GG up (83) n.d.
down
(89)
positive regulation of heterotypic cell-cell adhesion
(GO:0034116)
10 3 0.03 97.1 3.68E-
02
plasminogen activation (GO:0031639) 10 3 0.03 97.1 3.68E-
02
fibrinolysis (GO:0042730) 15 4 0.05 86.3 1.36E-
03
terminal ileum C59 up (132) n.d.
down
(176)
n.d.
GG up (95) brown fat cell differentiation (GO:0050873) 34 5 0.13 37.7 2.18E-
03
lymph node development (GO:0048535) 28 4 0.11 36.7 4.05E-
02
B cell receptor signaling pathway (GO:0050853) 52 5 0.2 24.7 1.73E-
02
regulation of leukocyte chemotaxis (GO:0002688) 101 6 0.39 15.2 2.53E-
02
B cell activation (GO:0042113) 155 8 0.6 13.2 1.55E-
03
cell chemotaxis (GO:0060326) 165 7 0.64 10.9 3.36E-
02
regulation of leukocyte migration (GO:0002685) 165 7 0.64 10.9 3.36E-
02
adaptive immune response (GO:0002250) 274 9 1.07 8.4 1.09E-
02
down
(143)
vasodilation (GO:0042311) 34 5 0.12 42.1 1.26E-
03
regulation of lipid metabolic process
(GO:0019216)
298 9 1.04 8.6 8.56E-
03
* number in () indicates the number of analyzed genes (FDR<0.05).
https://doi.org/10.1371/journal.pone.0188985.t002
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To identify the factors contributing to changes in gene expression in the terminal ileum, prin-
cipal component (PC) analysis (PCA) was performed using array data quantified by RMA (Fig
2A). Each gene had a loading in each principal component. PCA was used to determine whether
gene expression would be affected by different doses of LAB. PCA of all RMA data (7 groups,
n = 5) revealed that the cumulative proportion of top 15 PCs was 0.85. PC1 significantly contrib-
uted to the classification between control and GG-10^7 (p< 0.05), GG-10^8 (p = 0.05), and
GG-10^9 (p< 0.01), respectively, suggesting that administration of more than 1 × 107 CFU/day
of GG changed the gene expression of the host ileum. There was no significant difference
between groups at different doses of GG. The PCA plot showed that 14 out of 15 GG groups had
a positive PC1 coefficient value (Fig 2A). Conversely, PC3 significantly contributed to the classi-
fication between the control and the C59-10^8 group (p< 0.01). Eleven out of 15 C59 adminis-
tered groups had a negative coefficient value on PC3. The component loadings of PC1 and PC3
for each gene were plotted to detect the contribution to these two PCs (Fig 2B). Genes with
higher component loadings on PC1 and lower component loadings on PC3 were identified (S11
Table). Interestingly, genes with a high PC1 coefficient were found in DEGs identified in B cell-
related GO terms in Experiment 1. Thus, the expression of these genes, Ccr6,Cd79a,Cd79b,Cr2,
Cxcr5,Klhl6, Ms4a1, Tnfrsf13c, would characterize the effect of GG administration.
The result of PCA suggested that the administration of C59 and GG differentially affected
the gene expression in the terminal ileum.
In the case of GG administration, a difference in gene expression was observed in the GG-
10^7 group. We previously reported that a 7 day consecutive administration of GG (4 × 108
CFU/0.2 ml of PBS) to mice resulted in a marked increase in Tlr3 gene expression in the small
intestine, but did not alter the expression of genes encoding other TLRs [34]. In the current
study, a significant up-regulation of Tlr3 expression was observed in the groups administered
both GG and C59 (FDR < 0.05), except for the GG-10^9 group (FDR = 0.05). This was consis-
tent with the observation that LAB strains harbor more dsRNA than other examined patho-
genic bacteria [35]. In experiments that employ bone marrow-derived dendritic cells, LAB
induces IFN-β production via dsRNA [35]. Changes in the expression of the Ifnb1 gene encod-
ing IFN-β were not observed in the current study. TLR3 plays a key role in the innate immu-
nity [35, 48], and LAB administration would stimulate the host’s immune responses. The type
of dsRNA that is involved in the up-regulation of Tlr3 and the question of whether LAB
dsRNA is involved in the strain-specific probiotic effect should be investigated further.
To detect the dose-dependent effect of LAB administration on the biological processes in
the terminal ileum, the PANTHER over-representation test was employed, using lists of genes
up-regulated or down-regulated (FDR< 0.05) in each group administered LAB (S5–S10
Tables). Although neither the number of DEGs (Table 3) nor PCA (Fig 2) revealed dose-
related effects of LAB, gene list enrichment analysis revealed strain- and dose-related effects
on GO biological processes (Table 4). Significant enrichment of genes involved in “intestinal
absorption” (GO:0050892) was observed in both the C59-10^8 group (p = 0.0014) and the
Table 3. Number of differentially expressed genes (DEGs, FDR < 0.05) in the terminal ileum of mice administered different doses of C59 and GG.
administered LAB C59 GG
dose group 10^7 10^8 10^9 common DEGs a (C59) 10^7 10^8 10^9 common DEGs a (GG)
up-regulated 254 250 292 (157) 558 465 636 (254)
down-regulated 61 87 59 (10) 138 140 242 (63)
total 315 337 351 (167) 696 605 878 (317)
a Number of common DEGs in () is included in respective DEGs.
https://doi.org/10.1371/journal.pone.0188985.t003
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C59-10^9 group (p = 0.0050); in these groups, six genes, namely, Abcb1a, Aco1, Cd36, Fabp1,
Lep, and Slc5a1, were significantly up-regulated (FDR < 0.05).
Specific GO term enrichment was not apparent for down-regulated genes in GG animals.
Similar to the results of Experiment 1 (Table 1), enrichment of “B cell receptor signaling path-
way” and “B cell activation” processes was also observed in the GG-10^9 group in Experiment
2. These results suggested that GG cells interact specific intestinal immune cells to activate B
Fig 2. Principal component analysis of gene expression of the terminal ileum after the administration
of various doses of C59 and GG. A. PCA plot using PC1 and PC3 gene expression data quantified by RMA.
Each dot indicates control (Δ), C59-10^7 (), C59-10^8 (
), C59-10^9 (●), GG-10^7 (□), GG-10^8 (⊠), and
GG-10^9 (■) (n = 5 in each group). B, Plot of component loadings of PC1 and PC3 for all genes. Gene with
high PC values were numbered: 1, Hist1h2ao/Hist1h2ap; 2, C430003N24Rik; 3, Ms4a1; 4, Glycam; 5, Faim3;
6, Ighv14-2; 7, Cr2,; 8, Serpina1a; 9, P2ry10; 10. Mndal/Ifi205/Ifi204/Ifi211; 11, Ighg/Ighg2b; 12, Hmgb1l/
Hmgb1; 13, Arfgef3; 14, Igkv6-20; 15, 2810043O03Rik; 16, B830007D08Rik; 17, Slc6a14; 18, Retnlb; 19.
Saa1; and 20, Car1.
https://doi.org/10.1371/journal.pone.0188985.g002
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cells and administration of 1 × 109 CFU/day of GG cells is required to execute this activity.
The following 33 genes listed under “B cell receptor signaling pathway” and “B cell activation”
were up-regulated in GG-10^9 group: Aicda, Bank1, Blk, Btk, Btla, Ccr6, Cd19, Cd24a, Cd40,
Cd79a,Cd79b,Cr2, Cxcr5, Fnip1, Gcsam, Hhex, Ighg, Ighg1, Ighg3, Ighv14-2, Il2rg, Klhl6, Lyl1,
Malt1, Mef2c, Ms4a1, Pawr, Ptprc, Sash3, Stap1, Tfrc, Tnfrsf13b, and Tnfrsf13c. Such enrich-
ment was not observed in either the GG-10^7 or the GG-10^8 group, indicating that adminis-
tration of 1 × 109 CFU/day of GG increased the expression of B-cell related genes. Among B-
cell related genes, Aicda, Bank1, Btla, Ccr6, Cd19, Cd79a,Cd79b,Cr2, Cxcr5, Ighv14-2, Klhl6,
Ms4a1, Stap1, and Tnfrsf13c were also among the top 50 genes with high PC1 loading (S11
Table 4. PANTHER Overrepresentation Test of gene expression in terminal ileum of mice administered GG and C59.
Group up/down
() *
GO biological process Ref-list
(22322)
loaded expected Fold
enrichment
P-
value
C59
10^7
up (255) n.d.
down
(1)
n.d.
C59
10^8
up
(251)
intestinal absorption (GO:0050892) 26 6 0.24 25.5 0.0014
!digestive system process (GO:0022600) 58 7 0.52 13.34 0.0101
down
(88)
regulation of plasma lipoprotein particle levels (GO:0097006) 43 4 0.07 56.12 0.0069
C59
10^9
up (293) intestinal absorption (GO:0050892) 26 6 0.29 20.6 0.0050
steroid metabolic process (GO:0008202) 197 12 2.21 5.44 0.0245
glycerolipid metabolic process (GO:0046486) 250 15 2.8 5.36 0.0017
down
(59)
n.d.
GG
10^7
up (559) regulation of energy homeostasis (GO:2000505) 21 6 0.42 14.27 0.0416
triglyceride metabolic process (GO:0006641) 62 10 1.24 8.05 0.0058
regulation of lipid metabolic process (GO:0019216) 298 20 5.97 3.35 0.0309
down
(138)
n.d.
GG
10^8
up (435) lipid modification (GO:0030258) 153 13 2.59 5.02 0.0244
glycerolipid metabolic process (GO:0046486) 250 18 4.23 4.25 0.0035
down
(141)
n.d.
GG
10^9
up (637) B cell receptor signaling pathway (GO:0050853) 52 9 1.09 8.22 0.0176
!immune response-regulating cell surface receptor signaling pathway
(GO:0002768)
126 14 2.65 5.28 0.0059
regulation of B cell proliferation (GO:0030888) 64 11 1.35 8.16 0.0014
!regulation of lymphocyte proliferation (GO:0050670) 208 17 4.38 3.88 0.0252
positive regulation of adaptive immune response based on somatic
recombination of immune receptors built from immunoglobulin
superfamily domains (GO:0002824)
91 11 1.92 5.74 0.0412
B cell activation (GO:0042113) 155 17 3.26 5.21 0.0005
positive regulation of cell activation (GO:0050867) 294 21 6.19 3.39 0.0149
down
(242)
n.d.
* number in () indicates the number of analyzed genes (FDR<0.05).
https://doi.org/10.1371/journal.pone.0188985.t004
Lactic acid bacterium intake and murine ileal gene expression
PLOS ONE | https://doi.org/10.1371/journal.pone.0188985 December 8, 2017 11 / 18
Table). Interestingly, the expression of these genes decreased with an increasing dose of
administered C59, while it increased with an increasing dose of administered GG. Specifically,
the expression of Cd79b,Cxcr5, Aicda, and Ccr6 genes was down-regulated in the C59-10^8
and C59-10^9 groups. Concerning the adherence to the intestinal epithelial cells, GG is well
known to adhere to the intestinal mucus via the pili [12], whereas C59 is quickly excreted with
the feces, 6 h after oral administration [28]. The ability of GG to persist in the intestinal tract
longer than C59 may explain its greater immunostimulatory effect. However, the observed
opposite effect on gene expression cannot be explained by the strain’s adherence ability. Strain
C59 weakly stimulates macrophages, inducing the production of low levels of such inflamma-
tory cytokines, such as IL-12 [28, 49]. In addition, oral administration of live C59 suppressed
IgE antibody production in OVA-sensitized mice [28]. This suggests that the difference in the
effect of C59 and GG on murine gene expression is not associated with the difference between
Lactobacillus and Lactococcus, but is strain-specific.
We previously observed a significant down-regulation (p< 0.001) of genes involved in the
immune response in the terminal ileum in mice exposed to sub-chronic and mild social defeat
stress, a murine model of depression [50]. Because GG can stimulate B cell-related pathways in
the terminal ileum, intake of GG may attenuate stress-induced symptoms, including perturba-
tion of the intestinal microbiota and metabolites, by stimulating the immune responses.
The effect of LAB administration on the amount of secretory IgA in feces
To investigate the effect of oral C59 and GG administration on the mucosal immune system,
fecal secretory IgA levels were compared before and after a 15-day administration of these
LAB strains. Statistical analysis (the MIXED procedure) showed that the effects of LAB-treat
(control, C59, GG) and Days (day 1, day 15) were not significant. No statistically significant
interaction between LAB-treat and Days was observed (P = 0.13). The levels of secretory IgA
before and after LAB administration are shown in Fig 3. Concentrations of secretory IgA were
Fig 3. Fecal concentration of secretory IgA before and after LAB administration. The fecal concentration
of secretory IgA before and after administration of C59 or GG during experiment 2 was determined using
ELISA. The white and gray bars represent the concentration of secretory IgA (μg/ml) before and after LAB
administration, respectively. The data are shown as the least-squares means ± SE (n = 5 in each group).
https://doi.org/10.1371/journal.pone.0188985.g003
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also examined in intestinal fluids. The concentrations in control, C59 and GG groups were
1.17 ± 0.42, 1.12 ± 0.60 and 1.34 ± 0.74 (μg/μg protein), respectively, demonstrating that there
was no significant difference (p = 0.94) between the three groups.
Viable GG cells stimulate rotavirus-specific IgA responses in patients with rotavirus diar-
rhea [51], while non-viable GG stains enhance the systemic and mucosal immune responses,
resulting in the elevation of OVA-specific secretory IgA levels in OVA-sensitized mouse [52].
In our experiments, the fecal secretory IgA levels in non-sensitized mice were not significantly
affected by a 2 week administration of GG. Other than GG, Carasi et al. investigated the induc-
tion of IgA levels after a 14 d administration of Lactobacillus kefiri; the IgA levels were further
increased after 21 d administration [53]. Oral administration of Lactobacillus plantarum strain
AYA for 28 d enhances IgA secretion and increases survival rates following influenza virus
infection in mouse [54]. The duration and dose of LAB administration required to observe
enhanced IgA secretion are strain-dependent and critical for understanding immune
responses to LAB.
The effect of LAB administration on CXCR5-positive ILFs
The mucosal immune system of the intestine comprises the intestinal lamina propria cells and
the intraepithelial lymphocytes, in addition to such organized lymphoid structures as the
Peyer’s patches (PPs) and ILFs. Unlike the programmed development of PPs, the maturation
of ILFs from cryptopatches requires induction by the intestinal microbiota [55]. The chemo-
kines CCL20 and CXCL13, and their respective receptors CCR6 and CXCR5, play a role in the
development of ILFs [56–58]. The expression of Ccl20 and Cxcl13, and their respective recep-
tor genes (Ccr6 and Cxcr5), in the ILFs of aged mice were 3–4 fold lower than those of young
mice [56]. In the current study, compared with control group, the expression of the Cxcl13
(ranked 32 among the up-regulated DEGs, FDR< 0.001), Cxcr5 (ranked 57 among the up-reg-
ulated DEGs, FDR< 0.001), and Ccr6 genes (ranked 94 among the up-regulated DEGs,
FDR< 0.001) was significantly increased in the GG-10^9 group; the expression of Ccl20 was
not significantly changed.
We also examined the effect of oral GG administration on ILF development. After 2 weeks
of GG administration (1 × 109 CFU/day), the small intestines were stained with anti-CXCR5
antibody, and CXCR5-positive ILFs were counted. No significant differences in the number of
CXCR5-positive ILFs in the control group and mice administered GG were observed (Fig 4).
The terminal ileum, evaluated by the microarray analysis, was located in segment D, where the
number of ILFs was lower than in other segments. The number of ILFs was not significantly
affected by GG administration. Further studies are required to identify the immune cells rec-
ognizing individual GG cells and the mechanism through which the mucosal immune system
is up-regulated by GG administration.
Conclusions
In the current study, the effect of oral LAB administration on gene expression in the small
intestine was investigated using a conventional mouse model. Intestinal site-specific, strain-
specific, and dose-specific gene expression was observed. The oral administration of strains
C59 and GG significantly (FDR < 0.05) down-regulated the expression of genes encoding
fibrinogen subunits and plasminogen in the upper small intestine. PCA revealed that oral
administration of GG changed gene expression of the terminal ileum at a dose of at least
1 × 107 CFU/day for 2 weeks. Although the hierarchical cluster analysis showed that adminis-
tration of LAB did not affect overall gene expression, gene list enrichment analysis suggested
that distinct strains would interact with specific intestinal cells and differentially affect their
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gene expression as reflected by various GO biological processes. Genes associated with the B
cell receptor signaling pathway and B cell activation were up-regulated in the terminal ileum
following GG administration at a dose of 1 × 107 CFU/day, in agreement with the reported
immunostimulatory effects of GG. The distinct effects of GG and C59 on gene expression in
the small intestine will provide useful information about intestinal responses of healthy ani-
mals to probiotic strains and clues to understanding the strain-specific mechanisms of probi-
otic action.
Supporting information
S1 Fig. Comparison of the hierarchical clustering dendrograms obtained by the three data-
quantification methods. Raw data from the upper small intestine and the terminal ileum were
quantified by qFARM, DFW, and RMA, as indicated. Left panels are data from the upper
small intestine and right panels are those from the terminal ileum. Each sample name com-
prises the strain name (cont, control; C59, L. lactis C59; GG, L. rhamonosus GG) and the num-
ber corresponding to the individual mouse. The vertical scale represents the distance between
clusters.
(EPS)
S1 Table. DEGs of upper ileum administered C59 (FDR<0.05).
(XLSX)
S2 Table. DEGs of upper ileum administered GG (FDR<0.05).
(XLSX)
S3 Table. DEGs of terminal ileum administered C59 (FDR<0.05).
(XLSX)
Fig 4. The effect of GG administration on the number of CXCR5-positive ILFs in the murine small
intestine. After 2 weeks of GG administration (1 × 109 CFU/day) or PBS (n = 5 in each group), the small
intestines were divided into four equal segments, from proximal to distal (A–D), labeled with anti-CXCR5
antibody and HRP-conjugated anti-rabbit antibody, and visualized with DAB. The CXCR5-positive ILFs in
each intestinal fragment were counted under a stereomicroscope.
https://doi.org/10.1371/journal.pone.0188985.g004
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